T1	Participants 40 54	heroin addicts
T2	Participants 408 446	Patients who received placebo (n = 18)
#1	AnnotatorNotes T2	one group - n=18
T3	Participants 559 598	Patients who received naloxone (n = 58)
#2	AnnotatorNotes T3	other group n=58
